IRIS Accounts Production v26.1.0.640 03698954 Board of Directors 1.11.24 31.10.25 31.10.25 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh036989542024-10-31036989542025-10-31036989542024-11-012025-10-31036989542023-10-31036989542023-11-012024-10-31036989542024-10-3103698954ns15:EnglandWales2024-11-012025-10-3103698954ns14:PoundSterling2024-11-012025-10-3103698954ns10:Director12024-11-012025-10-3103698954ns10:PrivateLimitedCompanyLtd2024-11-012025-10-3103698954ns10:SmallEntities2024-11-012025-10-3103698954ns10:AuditExempt-NoAccountantsReport2024-11-012025-10-3103698954ns10:SmallCompaniesRegimeForDirectorsReport2024-11-012025-10-3103698954ns10:SmallCompaniesRegimeForAccounts2024-11-012025-10-3103698954ns10:FullAccounts2024-11-012025-10-3103698954ns10:OrdinaryShareClass12024-11-012025-10-3103698954ns10:Director42024-11-012025-10-3103698954ns10:Director52024-11-012025-10-3103698954ns10:RegisteredOffice2024-11-012025-10-3103698954ns5:CurrentFinancialInstruments2025-10-3103698954ns5:CurrentFinancialInstruments2024-10-3103698954ns5:ShareCapital2025-10-3103698954ns5:ShareCapital2024-10-3103698954ns5:RetainedEarningsAccumulatedLosses2025-10-3103698954ns5:RetainedEarningsAccumulatedLosses2024-10-3103698954ns5:LeaseholdImprovements2024-11-012025-10-3103698954ns5:PlantMachinery2024-11-012025-10-3103698954ns5:FurnitureFittings2024-11-012025-10-3103698954ns5:MotorVehicles2024-11-012025-10-3103698954ns5:ComputerEquipment2024-11-012025-10-3103698954ns5:LeaseholdImprovements2024-10-3103698954ns5:PlantMachinery2024-10-3103698954ns5:FurnitureFittings2024-10-3103698954ns5:LeaseholdImprovements2025-10-3103698954ns5:PlantMachinery2025-10-3103698954ns5:FurnitureFittings2025-10-3103698954ns5:LeaseholdImprovements2024-10-3103698954ns5:PlantMachinery2024-10-3103698954ns5:FurnitureFittings2024-10-3103698954ns5:MotorVehicles2024-10-3103698954ns5:ComputerEquipment2024-10-3103698954ns5:MotorVehicles2025-10-3103698954ns5:ComputerEquipment2025-10-3103698954ns5:MotorVehicles2024-10-3103698954ns5:ComputerEquipment2024-10-3103698954ns5:WithinOneYearns5:CurrentFinancialInstruments2025-10-3103698954ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-3103698954ns10:OrdinaryShareClass12025-10-3103698954ns5:RetainedEarningsAccumulatedLosses2024-10-3103698954ns5:RetainedEarningsAccumulatedLosses2024-11-012025-10-3103698954ns10:Director22024-11-012025-10-31036989542ns10:Director22024-10-31036989542ns10:Director22023-10-31036989542ns10:Director22024-11-012025-10-31036989542ns10:Director22023-11-012024-10-31036989542ns10:Director22025-10-31036989542ns10:Director22024-10-31
REGISTERED NUMBER: 03698954 (England and Wales)















Financial Statements for the Year Ended 31 October 2025

for

A & M Pharmacies Limited

A & M Pharmacies Limited (Registered number: 03698954)






Contents of the Financial Statements
for the Year Ended 31 October 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


A & M Pharmacies Limited

Company Information
for the Year Ended 31 October 2025







DIRECTORS: Mr Kishore Sharma
Mr Tushar Mahendrakumar Patel
Mrs Aartiben Patel





REGISTERED OFFICE: 126 Sutherland Avenue
Coventry
West Midlands
CV5 7NJ





REGISTERED NUMBER: 03698954 (England and Wales)






A & M Pharmacies Limited (Registered number: 03698954)

Statement of Financial Position
31 October 2025

31.10.25 31.10.24
Notes £    £    £    £   
FIXED ASSETS
Property, plant and equipment 4 105,504 105,072

CURRENT ASSETS
Inventories 5 144,624 209,233
Debtors 6 369,383 339,487
Cash at bank and in hand 528,526 371,073
1,042,533 919,793
CREDITORS
Amounts falling due within one year 7 491,347 431,923
NET CURRENT ASSETS 551,186 487,870
TOTAL ASSETS LESS CURRENT
LIABILITIES

656,690

592,942

PROVISIONS FOR LIABILITIES 12,382 10,856
NET ASSETS 644,308 582,086

CAPITAL AND RESERVES
Called up share capital 8 100 100
Retained earnings 9 644,208 581,986
SHAREHOLDERS' FUNDS 644,308 582,086

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

A & M Pharmacies Limited (Registered number: 03698954)

Statement of Financial Position - continued
31 October 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 July 2026 and were signed on its behalf by:





Mr Tushar Mahendrakumar Patel - Director


A & M Pharmacies Limited (Registered number: 03698954)

Notes to the Financial Statements
for the Year Ended 31 October 2025

1. STATUTORY INFORMATION

A & M Pharmacies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 15% on reducing balance
Plant and machinery - 15% on reducing balance
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance
Computer equipment - 15% on reducing balance

Stocks
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 32 (2024 - 38 ) .

A & M Pharmacies Limited (Registered number: 03698954)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2025

4. PROPERTY, PLANT AND EQUIPMENT
Improvements Fixtures
to Plant and and
property machinery fittings
£    £    £   
COST
At 1 November 2024 318,688 58,355 460,662
Additions - 19,600 -
At 31 October 2025 318,688 77,955 460,662
DEPRECIATION
At 1 November 2024 284,484 47,260 427,635
Charge for year 5,131 4,604 4,954
At 31 October 2025 289,615 51,864 432,589
NET BOOK VALUE
At 31 October 2025 29,073 26,091 28,073
At 31 October 2024 34,204 11,095 33,027

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 November 2024 15,130 87,047 939,882
Additions - - 19,600
At 31 October 2025 15,130 87,047 959,482
DEPRECIATION
At 1 November 2024 10,451 64,980 834,810
Charge for year 1,169 3,310 19,168
At 31 October 2025 11,620 68,290 853,978
NET BOOK VALUE
At 31 October 2025 3,510 18,757 105,504
At 31 October 2024 4,679 22,067 105,072

5. INVENTORIES
31.10.25 31.10.24
£    £   
Stocks 144,624 209,233

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.25 31.10.24
£    £   
Trade debtors 279,666 215,996
Other debtors 89,717 123,491
369,383 339,487

A & M Pharmacies Limited (Registered number: 03698954)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.10.25 31.10.24
£    £   
Trade creditors 440,611 386,582
Taxation and social security 48,788 20,467
Other creditors 1,948 24,874
491,347 431,923

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.10.25 31.10.24
value: £    £   
100 Ordinary £1 100 100

9. RESERVES
Retained
earnings
£   

At 1 November 2024 581,986
Profit for the year 112,222
Dividends (50,000 )
At 31 October 2025 644,208

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 October 2025 and 31 October 2024:

31.10.25 31.10.24
£    £   
Mr Ashwin Lalji Hindocha
Balance outstanding at start of year - 130,000
Amounts repaid - (130,000 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -